Mutant fibroblast growth factor receptor 3 induces intracellular signaling and cellular transformation in a cell type- and mutation-specific manner

作者: E di Martino , C G L'Hôte , W Kennedy , D C Tomlinson , M A Knowles

DOI: 10.1038/ONC.2009.280

关键词:

摘要: Although activating mutations of fibroblast growth factor receptor 3 (FGFR3) are frequent in bladder tumors, little information is available on their specific effects urothelial cells or the basis for observed mutation spectrum. We investigated phenotypic and signaling consequences three FGFR3 (S249C, Y375C, K652E) immortalized normal human (TERT-NHUC) mouse fibroblasts (NIH-3T3). In TERT-NHUC, all mutant forms induced phosphorylation FRS2α ERK1/2, but not AKT SRC. PLCγ1 was only TERT-NHUC expressing common S249C Y375C mutations, rare K652E mutation. Cells displayed an increased saturation density, related to proliferation viability. This effect significantly dependent undetectable FGFR3, which failed phosphorylate PLCγ1. contrast expression NIH-3T3 resulted Src Akt. addition, were able Plcγ1 induce morphological transformation, cell proliferation, anchorage-independent growth. Our results indicate that both type specific. Mutant may confer a selective advantage urothelium by overcoming contact inhibition proliferation.

参考文章(46)
Penelope Korkolopoulou, Andreas Ch. Lazaris, Anastasia-E. Konstantinidou, Nikolaos Kavantzas, Efstratios Patsouris, Panayota Christodoulou, Euphemia Thomas-Tsagli, Panagiotis Davaris, Differential Expression of bcl-2 Family Proteins in Bladder Carcinomas: Relationship with Apoptotic Rate and Survival European Urology. ,vol. 41, pp. 274- 283 ,(2002) , 10.1016/S0302-2838(02)00003-9
J. William Harbour, Douglas C. Dean, Rb function in cell-cycle regulation and apoptosis Nature Cell Biology. ,vol. 2, ,(2000) , 10.1038/35008695
David Cappellen, Catherine De Oliveira, David Ricol, Sixtina de Medina, Jérôme Bourdin, Xavier Sastre-Garau, Dominique Chopin, Jean Paul Thiery, François Radvanyi, Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas. Nature Genetics. ,vol. 23, pp. 18- 20 ,(1999) , 10.1038/12615
Kathryn Sibley, Darren Cuthbert-Heavens, Margaret A Knowles, None, Loss of heterozygosity at 4p16.3 and mutation of FGFR3 in transitional cell carcinoma. Oncogene. ,vol. 20, pp. 686- 691 ,(2001) , 10.1038/SJ.ONC.1204110
H Yamamoto, T Monden, K Ikeda, H Izawa, K Fukuda, M Fukunaga, N Tomita, T Shimano, H Shiozaki, M Monden, Coexpression of cdk2/cdc2 and retinoblastoma gene products in colorectal cancer. British Journal of Cancer. ,vol. 71, pp. 1231- 1236 ,(1995) , 10.1038/BJC.1995.238
Domenica Ronchetti, Angela Greco, Silvana Compasso, Gualtiero Colombo, Patrizia Dell'Era, Takemi Otsuki, Luigia Lombardi, Antonino Neri, Deregulated FGFR3 mutants in multiple myeloma cell lines with t(4;14): comparative analysis of Y373C, K650E and the novel G384D mutations. Oncogene. ,vol. 20, pp. 3553- 3562 ,(2001) , 10.1038/SJ.ONC.1204465
Patricia M.-J. Lievens, Alessandro Roncador, Elio Liboi, K644E/M FGFR3 Mutants Activate Erk1/2 from the Endoplasmic Reticulum through FRS2α and PLCγ-independent Pathways Journal of Molecular Biology. ,vol. 357, pp. 783- 792 ,(2006) , 10.1016/J.JMB.2006.01.058